B
ELV icon

Bailard’s Elevance Health ELV Stock Holding History

Bailard’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.44M Sell
3,725
-826
-18% -$306K 0.03% 295
2026
Q1 		$1.33M Sell
4,551
-166
-4% -$54.6K 0.03% 281
2025
Q4 		$1.65M Buy
4,717
+632
+15% +$214K 0.04% 253
2025
Q3 		$1.32M Buy
4,085
+871
+27% +$271K 0.03% 293
2025
Q2 		$1.25M Buy
3,214
+1,421
+79% +$572K 0.03% 297
2025
Q1 		$780K Buy
1,793
+116
+7% +$46.6K 0.02% 348
2024
Q4 		$619K Sell
1,677
-4,609
-73% -$1.93M 0.02% 422
2024
Q3 		$3.27M Buy
6,286
+129
+2% +$68.9K 0.09% 186
2024
Q2 		$3.34M Sell
6,157
-95
-2% -$50.2K 0.09% 173
2024
Q1 		$3.24M Sell
6,252
-488
-7% -$243K 0.09% 181
2023
Q4 		$3.18M Buy
6,740
+173
+3% +$80K 0.09% 177
2023
Q3 		$2.86M Sell
6,567
-10
-0.2% -$4.54K 0.09% 174
2023
Q2 		$2.92M Sell
6,577
-4,956
-43% -$2.29M 0.1% 157
2023
Q1 		$5.3M Buy
11,533
+20
+0.2% +$9.52K 0.19% 109
2022
Q4 		$5.91M Sell
11,513
-122
-1% -$61.9K 0.23% 98
2022
Q3 		$5.29M Buy
11,635
+1,080
+10% +$517K 0.22% 102
2022
Q2 		$5.09M Sell
10,555
-309
-3% -$153K 0.2% 106
2022
Q1 		$5.34M Buy
10,864
+36
+0.3% +$16.5K 0.18% 110
2021
Q4 		$5.02M Hold
10,828
– – 0.16% 122
2021
Q3 		$4.04M Buy
10,828
+54
+0.5% +$20.5K 0.14% 140
2021
Q2 		$4.11M Sell
10,774
-1,155
-10% -$441K 0.14% 139
2021
Q1 		$4.28M Buy
+11,929
New +$3.84M 0.16% 124
2015
Q4 		– Sell
-19,791
Closed -$2.77M – 247
2015
Q3 		$2.77M Buy
19,791
+705
+4% +$106K 0.43% 35
2015
Q2 		$3.13M Buy
19,086
+400
+2% +$63.9K 0.48% 33
2015
Q1 		$2.88M Buy
18,686
+134
+0.7% +$19.1K 0.4% 37
2014
Q4 		$2.33M Buy
18,552
+147
+0.8% +$18.2K 0.33% 49
2014
Q3 		$2.2M Buy
18,405
+168
+0.9% +$19.3K 0.34% 47
2014
Q2 		$1.96M Buy
+18,237
New +$1.88M 0.3% 58

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bailard's ELV Position: Q2 2026 in Review

Bailard reduced its Elevance Health (ELV) stake by 18% in Q2 2026, selling an estimated $306K and leaving 3,725 shares worth $1.44M. The position accounts for 0.03% of the portfolio, ranked #295.

Bailard first reported a position in ELV in Q2 2014 and has held it in 28 quarters since. The position peaked at $5.91M in Q4 2022. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Bailard held 3,725 shares of Elevance Health worth $1.44M as of Q2 2026.
  • Bailard sold 826 Elevance Health shares in Q2 2026, an estimated $306K.
  • Elevance Health made up 0.03% of Bailard's portfolio in Q2 2026, its #295 holding.
  • Bailard first reported a position in Elevance Health in Q2 2014 and has held it in 28 quarters since.
  • Bailard's Elevance Health position peaked at $5.91M in Q4 2022.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Bailard's 13F filing for Q2 2026, filed 30 Jul 2026.